Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on German Banking & Finance News.
ERES Declares August 2025 Monthly Distribution
GlobeNewswire, Inc.
·
August 15, 2025
TORONTO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) is pleased to announce that the trustees of ERES have declared the August 2025 monthly cash distribution of €0.005 per Unit and...
Germany blames Israel for ensuring humanitarian aid reaches Gaza
MENAFN
·
August 6, 2025
(MENAFN) The German government stressed on Saturday that Israel is responsible for ensuring the full delivery of humanitarian aid to Gaza, with support from the UN and other aid groups. Government spokesperson Stefan Kornelius said Foreign...
Media reports Germany to cut payments for Ukrainians
MENAFN
·
August 9, 2025
(MENAFN) Germany’s Labor Ministry has proposed reducing welfare payments for newly arriving Ukrainian migrants, citing mounting financial strain from continued inflows. According to German media, Labor Minister Barbel Bas has submitted a draft...
Germany Mulls Scaling Back Ukrainian Refugee Benefits
MENAFN
·
August 4, 2025
(MENAFN) A top official in German Chancellor Friedrich Merz’s administration on Monday endorsed a controversial proposal to scale back social welfare for Ukrainian refugees, aligning with a demand from the government’s coalition partner. Thorsten...
Germany states Israel responsible for ensuring humanitarian assistance reaches Gaza
MENAFN
·
August 4, 2025
(MENAFN) The German government reiterated on Saturday that Israel bears the responsibility for guaranteeing the delivery of full-scale humanitarian assistance to Gaza, in coordination with the UN and other aid groups. Government spokesperson...
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 7, 2025
Announced positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug...
Alector Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 7, 2025
On track to report topline data by mid-Q4 2025 from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN, a severe, rare form of dementia with no approved treatments Ongoing Phase 2 PROGRESS-AD trial of AL101 in early Alzheimer’s...
Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 7, 2025
Regulatory Reviews of Aficamten for Obstructive HCM Progressing in U.S., E.U. and China; Late-Cycle Meeting with U.S. FDA Scheduled for September Ahead of December 26, 2025 PDUFA Date Primary Results from MAPLE-HCM to be Presented in a Hot Line...
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
GlobeNewswire, Inc.
·
August 7, 2025
CAB-EpCAM x CAB-CD3 bispecific T-cell engager (TCE) (BA3182) Phase 1 dose-escalation study ongoing, currently dosing 1.2 mg cohort; Phase 1 data readout expected 2H 2025 Fast Track Designated Ozuriftamab vedotin (Oz-V; CAB-ROR2-ADC) Phase 2 study...
Summit Equity Partners Ltd Launches Flagship AegisX System, Pioneering Independent Financial Education and AI-Driven Quantitative Investment Solutions
GlobeNewswire, Inc.
·
August 7, 2025
Denver, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Summit Equity Partners Ltd, a leading U.S.-based independent financial education and research institution, proudly announces the launch of AegisX 4.0, its cutting-edge, AI-powered quantitative wealth...
Lifeward to Report Second Quarter Financial Results on August 14, 2025
GlobeNewswire, Inc.
·
August 7, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations...
Peloton Interactive, Inc. Reports Fourth Quarter & Fiscal Year 2025 Financial Results
GlobeNewswire, Inc.
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (Nasdaq: PTON) has announced its financial results for the fourth quarter and fiscal year 2025. Please visit the Peloton investor relations website to view the shareholder...
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 7, 2025
INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025 Phase 1/2 data announced by Staidson BioPharmaceuticals for InflaRx-partnered C5a antibody...
Himax Technologies, Inc. Reports Second Quarter 2025 Financial Results; Provides Third Quarter Guidance
GlobeNewswire, Inc.
·
August 7, 2025
Q2 2025 Gross Margin Exceeded Guidance, Revenues and EPS In-Line with the Guidance Range Issued on May 8, 2025 Company Q3 2025 Guidance: Revenues to Decrease 12% to 17% QoQ, Gross Margin is Expected to be Around 30%. Loss per Diluted ADS to be 2.0...
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
GlobeNewswire, Inc.
·
August 7, 2025
COPENHAGEN, Denmark, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SNIPR Biome ApS (“SNIPR”), the company pioneering the development of microbial CRISPR-medicine, today announced the close of a EUR 35 million Series B raise with funding from new investors the...
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
GlobeNewswire, Inc.
·
August 7, 2025
The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD data readout expected early in the fourth quarter of 2025; The multiple ascending dose (MAD) part of the AVALON trial initiated; Available...
Immunocore reports second quarter financial results and provides a business update
GlobeNewswire, Inc.
·
August 7, 2025
KIMMTRAK® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year Phase 3 TEBE-AM trial on track to complete enrollment in 1H 2026 Dose selection for PRISM-MEL-301 Phase 3 trial expected in 2H 2025 Phase 1 single...
C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
·
August 7, 2025
Cemsidomide Phase 1 Data in Multiple Myeloma Accepted as an Oral Presentation at the International Myeloma Society (IMS) Annual Meeting; As of the July 23, 2025, Data Cutoff, Phase 1 ORR Remains at 40% at the 75 µg Dose Level and at 50% at the 100...
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 7, 2025
CLN-978 program now actively enrolling across Phase 1 studies in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and Sjögren’s disease BCMA-directed bispecific T cell engager velinotamig in-licensed from Genrix Bio Zipalertinib...
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
GlobeNewswire, Inc.
·
August 6, 2025
Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS),...